ARTICLE | Company News
Aradigm, Grifols deal
June 9, 2014 7:00 AM UTC
Aradigm received a $5 million milestone payment from Grifols under a 2013 deal granting Grifols exclusive, worldwide rights to develop and commercialize Aradigm's formulations of inhaled ciprofloxacin...